Renal and vascular glutathione S-transferase μ is not affected by pharmacological intervention to reduce systolic blood pressure

Journal of Hypertension

Volumn 27, Issue 8, 2009, Pages 1575-1584

  Koh Tan, Han Hui Caline ^a   Graham, Delyth ^a   Hamilton, Carlene A ^a   Nicoll, Gavin ^a   Fields, Laura ^a   McBride, Martin W ^a   Young, Barbara ^b   Dominiczak, Anna F ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

Author keywords

Antihypertensive therapy; Blood pressure; Glutathione S transferase m; Oxidative stress; Rats; Stroke prone spontaneously hypertensive rats

Indexed keywords

ACETYLCYSTEINE; GLUTATHIONE; GLUTATHIONE TRANSFERASE M1; HYDRALAZINE PLUS HYDROCHLOROTHIAZIDE; ISOPROTEIN; OLMESARTAN; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR SYSTEM; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; GENETIC DISORDER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY; MALE; MULTIGENE FAMILY; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; STATISTICAL SIGNIFICANCE; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; WISTAR KYOTO RAT;

EID: 68449094441     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32832cc5a1     Document Type: Article

References (56)

1. Cowley AW Jr. The genetic dissection of essential hypertension. Nat Rev Genet 2006; 7:829-840.
2. Staessen JA, Wang J, Bianchi G, Birkenhager WH. Essential hypertension. Lancet 2003; 361:1629-1641.
3. Dominiczak AF, Negrin DC, Clark JS, Brosnan MJ, McBride MW, Alexander MY. Genes and hypertension: from gene mapping in experimental models to vascular gene transfer strategies. Hypertension 2000; 35 (1Pt 2):164-172.
4. Dominiczak AF, Brain N, Charchar F, McBride M, Hanlon N, Lee WK. Genetics of hypertension: lessons learnt from mendelian and polygenic syndromes. Clin Exp Hypertens 2004; 26:611-620.
5. Marteau JB, Zaiou M, Siest G, Visvikis-Siest S. Genetic determinants of blood pressure regulation. J Hypertens 2005; 23:2127-2143.
6. Monti J, Plehm R, Schulz H, Ganten D, Kreutz R, Hubner N. Interaction between blood pressure quantitative trait loci in rats in which trait variation at chromosome 1 is conditional upon a specific allele at chromosome 10. Hum Mol Genet 2003; 12:435-439.
7. Rapp JP. Genetic analysis of inherited hypertension in the rat. Physiol Rev 2000; 80:135-172.
8. Sugiyama F, Churchill GA, Higgins DC, Johns C, Makaritsis KP, Gavras H, et al. Concordance of murine quantitative trait loci for salt-induced hypertension with rat and human loci. Genomics 2001; 71:70-77.
9. Jeffs B, Negrin CD, Graham D, Clark JS, Anderson NH, Gauguier D, et al. Applicability of a 'speed' congenic strategy to dissect blood pressure quantitative trait loci on rat chromosome 2. Hypertension 2000; 35 (1Pt 2):179-187.
10. Clark JS, Jeffs B, Davidson AO, Lee WK, Anderson NH, Bihoreau MT, et al. Quantitative trait loci in genetically hypertensive rats. Possible sex specificity. Hypertension 1996; 28:898-906.
11. Takahashi N, Smithies O. Human genetics, animal models and computer simulations for studying hypertension. Trends Genet 2004; 20:136-145.
12. McBride MW, Carr FJ, Graham D, Anderson NH, Clark JS, Lee WK, et al. Microarray analysis of rat chromosome 2 congenic strains. Hypertension 2003; 41(3 Pt 2):847-853.
13. Garrett MR, Zhang X, Dukhanina Ol, Deng AY, Rapp JP. Two linked blood pressure quantitative trait loci on chromosome 10 defined by Dahl rat congenic strains. Hypertension 2001; 38:779-785.
14. Cicila GT, Choi C, Dene H, Lee SJ, Rapp JP. Two blood pressure/cardiac mass quantitative trait loci on chromosome 3 in Dahl rats. Mamm Genome 1999; 10:112-116.
15. Meng H, Garrett MR, Dene H, Rapp JP. Localization of a blood pressure QTL to a 2.4-cM interval on rat chromosome 9 using congenic strains. Genomics 2003; 81:210-220.
16. Pravenec M, Kren V, Krenova D, Zidek V, Simakova M, Musilova A, et al. Genetic isolation of quantitative trait loci for blood pressure development and renal mass on chromosome 5 in the spontaneously hypertensive rat. Physiol Res 2003; 52:285-289.
17. Monti J, Zimdahl H, Schulz H, Plehm R, Ganten D, Hubner N. The role of Wnk4 in polygenic hypertension: a candidate gene analysis on rat chromosome 10. Hypertension 2003; 41:938-942.
18. Kato N, Nabika T, Liang YQ, Mashimo T, Inomata H, Watanabe T, et al. Isolation of a chromosome 1 region affecting blood pressure and vascular disease traits in the stroke-prone rat model. Hypertension 2003; 42:1191-1197.
19. Kerr S, Brosnan MJ, Mclntyre M, Reid JL, Dominiczak AF, Hamilton CA. Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium. Hypertension 1999; 33:1353-1358.
20. McBride MW, Brosnan MJ, Mathers J, McLellan LI, Miller WH, Graham D, et al. Reduction of gstml expression in the stroke-prone spontaneously hypertension rat contributes to increased oxidative stress. Hypertension 2005; 45:786-792.
21. Polke JM, McBride MM, Nicklin SA, Baker AB, Graham D, Dominiczak AF. Promoter polymorphisms implicated in reduced expression of Gstml in the SHRSP. J Hyper Supp 2006; 24 (Supp 4):306.
22. Polke JM, McBride MM, Nicklin SA, Baker AB, Graham D, Dominiczak AF. Interactions between multiple promoter polymorphisms are required for reduced expression of Gstml in the SHRSP. J Hyper Supp 2006; 24 (Supp 6):284.
23. Hayes JD, McLellan LI. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free Radic Res 1999; 31:273-300.
24. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005; 45:51-88.
25. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995; 30:445-600.
26. Davidson AO, Schork N, Jaques BC, Kelman AW, Sutcliffe RG, Reid JL, et al. Blood pressure in genetically hypertensive rats. Influence of the Y chromosome. Hypertension 1995; 26:452-459.
27. Evans AL, Brown W, Kenyon CJ, Maxted KJ, Smith DC. Improved system for measuring systolic blood pressure in the conscious rat. Med Biol Eng Comput 1994; 32:101-102.
28. Mandai AK, Bell RD, Parker D, Nordquist JA, Lindeman RD. An analysis of the relationship of malignant lesions of the kidney to hypertension. Microvasc Res 1977; 14:279-292.
29. Berry C, Hamilton CA, Brosnan MJ, Magill FG, Berg GA, McMurray JJ, et al. Investigation into the sources of Superoxide in human blood vessels: angiotensin II increases Superoxide production in human internal mammary arteries. Circulation 2000; 101:2206-2212.
30. Wang XL, Greco M, Sim AS, Duarte N, Wang J, Wilcken DE. Glutathione S-transferase mu1 deficiency, cigarette smoking and coronary artery disease. J Cardiovasc Risk 2002; 9:25-31.
31. Aitman TJ, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, Wahid FN, et al. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet 1999; 21:76-83.
32. Pravenec M, Zidek V, Simakova M, Kren V, Krenova D, Horky K, et al. Genetics of Cd36 and the clustering of multiple cardiovascular risk factors in spontaneous hypertension. J Clin Invest 1999; 103:1651-1657.
33. Pravenec M, Landa V, Zidek V, Musilova A, Kren V, Kazdova L, et al. Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats. Nat Genet 2001; 27:156-158.
34. Brosnan MJ, Hamilton CA, Graham D, Lygate CA, Jardine E, Dominiczak AF. Irbesartan lowers Superoxide levels and increases nitric oxide bioavailability in blood vessels from spontaneously hypertensive stroke-prone rats. J Hypertens 2002; 20:281-286.
35. Tsuda M, Iwai M, Li JM, Li HS, Min LJ, Ide A, et al. Inhibitory effects of AT1receptor blocker, olmesartan, and estrogen on atherosclerosis via antioxidative stress. Hypertension 2005; 45:545-551.
36. Yao L, Kobori H, Rahman M, Seth DM, Shokoji T, Fan Y, et al. Olmesartan improves endothelin-induced hypertension and oxidative stress in rats. Hypertens Res 2004; 27:493-500.
37. Ellershaw DC, Gurney AM. Mechanisms of hydralazine induced vasodilation in rabbit aorta and pulmonary artery. Br J Pharmacol 2001; 134:621-631.
38. Wei S, Kasuya Y, Yanagisawa M, Kimura S, Masaki T, Goto K. Studies on endothelium-dependent vasorelaxation by hydralazine in porcine coronary artery. Eur J Pharmacol 1997; 321:307-314.
39. Anderson NH, Devlin AM, Graham D, Morton JJ, Hamilton CA, Reid JL, et al. Telemetry for cardiovascular monitoring in a pharmacological study: new approaches to data analysis. Hypertension 1999; 33 (1Pt 2):248-255.
40. Chanas SA, Jiang Q, McMahon M, McWalter GK, McLellan LI, Elcombe CR, et al. Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice. Biochem J 2002; 365 (Pt 2):405-416.
41. Chen YF, Cowley AW Jr, Zou AP. Increased H(2)O(2) counteracts the vasodilator and natriuretic effects of Superoxide dismutation by tempol in renal medulla. Am J Physiol Regul Integr Comp Physiol 2003; 285:R827-R833.
42. Sheehan D, Meade G, Foley VM, Dowd CA. Structure, function and evolution of glutathione transferases: implications for classification of nonmammalian members of an ancient enzyme superfamily. Biochem J 2001; 360 (Pt 1):1-16.
43. 2 leads to hypertension. Hypertension 2003; 42:25-30.
44. Mori T, Cowley AW Jr. Angiotensin II-NAD(P)H oxidase-stimulated Superoxide modifies tubulovascular nitric oxide cross-talk in renal outer medulla. Hypertension 2003; 42:588-593.
45. Makino A, Skelton MM, Zou AP, Roman RJ, Cowley AW Jr. Increased renal medullary oxidative stress produces hypertension. Hypertension 2002; 39 (2 Pt 2):667-672.
46. Nangaku M, Miyata T, Sada T, Mizuno M, Inagi R, Ueda Y, et al. Antihypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model. J Am Soc Nephrol 2003; 14:1212-1222.
47. Takahashi T, Konta T, Takasaki S, Ichikawa K, Takeishi Y, Kubota I. An angiotensin II type-1 receptor blocker, olmesartan medoxomil, attenuates lipid peroxidation in renal injury induced by subtotal nephrectomy. Clin Exp Nephrol 2007; 11:202-208.
48. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000; 87:840-844.
49. Meng S, Roberts U, Cason GW, Curry TS, Manning RD Jr. Superoxide dismutase and oxidative stress in Dahl salt-sensitive and -resistant rats. Am J Physiol Regul Integr Comp Physiol 2002; 283:R732-R738.
50. Yuan B, Liang M, Yang Z, Rute E, Taylor N, Olivier M, et al. Gene expression reveals vulnerability to oxidative stress and interstitial fibrosis of renal outer medulla to nonhypertensive elevations of ANG II. Am J Physiol Regul Integr Comp Physiol 2003; 284:R1219-R1230.
51. Hayes JD, Strange RC. Potential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress. Free Radic Res 1995; 22:193-207.
52. Chen N, Aleksa K, Woodland C, Rieder M, Koren G. W-Acetylcysteine prevents ifosfamide-induced nephrotoxicity in rats. Br J Pharmacol 2008; 153:1364-1372.
53. Nitescu N, Ricksten SE, Marcussen N, Haraldsson B, Nilsson U, Basu S, et al. N-acetylcysteine attenuates kidney injury in rats subjected to renal ischaemia-reperfusion. Nephrol Dial Transplant 2006; 21:1240-1247.
54. Tian N, Rose RA, Jordan S, Dwyer TM, Hughson MD, Manning RD Jr. N-Acetylcysteine improves renal dysfunction, ameliorates kidney damage and decreases blood pressure in salt-sensitive hypertension. J Hypertens 2006; 24:2263-2270.
55. Cabassi A, Dumont EC, Girouard H, Bouchard JF, Le Jossec M, Lamontagne D, et al. Effects of chronic N-acetylcysteine treatment on the actions of peroxynitrite on aortic vascular reactivity in hypertensive rats. J Hypertens 2001; 19:1233-1244.
56. Delies C, Padmanabhan S, Lee WK, Miller WH, McBride MW, McClure JD, et al. Glutathione S-transferase variants and hypertension. J Hypertens 2008; 26:1343-1352.